CATENA, Cristiana
 Distribuzione geografica
Continente #
NA - Nord America 15.706
EU - Europa 4.700
AS - Asia 947
Continente sconosciuto - Info sul continente non disponibili 22
AF - Africa 9
SA - Sud America 6
OC - Oceania 3
Totale 21.393
Nazione #
US - Stati Uniti d'America 15.615
UA - Ucraina 1.819
IT - Italia 888
DE - Germania 707
CN - Cina 668
FI - Finlandia 567
IE - Irlanda 307
SE - Svezia 185
TR - Turchia 162
CA - Canada 87
GB - Regno Unito 61
VN - Vietnam 54
BE - Belgio 36
RU - Federazione Russa 31
FR - Francia 30
EU - Europa 21
NL - Olanda 15
IR - Iran 14
ES - Italia 13
IN - India 13
KR - Corea 11
AT - Austria 8
TG - Togo 7
JP - Giappone 6
TW - Taiwan 5
EE - Estonia 4
PL - Polonia 4
RS - Serbia 4
AU - Australia 3
CH - Svizzera 3
IL - Israele 3
PH - Filippine 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
BT - Bhutan 2
CL - Cile 2
HR - Croazia 2
ME - Montenegro 2
MX - Messico 2
PE - Perù 2
PT - Portogallo 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AR - Argentina 1
BD - Bangladesh 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EG - Egitto 1
GL - Groenlandia 1
HK - Hong Kong 1
HU - Ungheria 1
ID - Indonesia 1
IM - Isola di Man 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LT - Lituania 1
LU - Lussemburgo 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 21.393
Città #
Woodbridge 2.091
Fairfield 1.829
Ann Arbor 1.474
Jacksonville 1.304
Houston 1.111
Chandler 975
Ashburn 839
Dearborn 788
Wilmington 782
Seattle 718
Cambridge 648
Princeton 336
Dublin 305
Beijing 292
Udine 169
Izmir 161
San Diego 128
Ottawa 78
Des Moines 74
Ogden 71
Hefei 64
Norwalk 64
Milan 59
Dong Ket 53
Nanjing 51
Kunming 49
Boardman 47
Redmond 47
San Mateo 45
Rome 35
Brussels 27
Grafing 25
Guangzhou 25
Falls Church 24
Helsinki 19
Jinan 18
New York 18
Washington 18
Mcallen 13
Fuzhou 12
Trieste 12
Codroipo 11
Indiana 11
Nanchang 11
Pignone 11
Hebei 10
Wuhan 10
Phoenix 9
Los Angeles 8
Saint Petersburg 8
Vicenza 8
Xian 8
Andover 7
Bitetto 7
Bologna 7
Hangzhou 7
Leawood 7
Lomé 7
Taranto 7
Turin 7
Vienna 7
Baotou 6
Chongqing 6
Nanning 6
Palermo 6
Shenyang 6
Simi Valley 6
Torre Del Greco 6
Castellammare Di Stabia 5
Changsha 5
Chengdu 5
Henderson 5
Madrid 5
Paris 5
Taipei 5
Venezia 5
Zhengzhou 5
Augusta 4
Bari 4
Belgrade 4
Catania 4
Frankfurt am Main 4
Lanzhou 4
Mascali 4
Maserada sul Piave 4
Mumbai 4
Pune 4
San Giuseppe Vesuviano 4
Taizhou 4
Tallinn 4
Tappahannock 4
Tavagnacco 4
Tokyo 4
Toronto 4
Wenzhou 4
Amsterdam 3
Ardabil 3
Berlin 3
Cantu 3
Edinburgh 3
Totale 15.240
Nome #
Decreased fibrinolytic activity is associated with carotid artery stiffening in arterial hypertension 237
Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies 152
Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: relevance for cardiovascular outcomes 141
Aldosterone and the heart: from basic research to clinical evidence 141
Aldosterone and Left Ventricular Remodeling 135
Mineralocorticoid Receptor Blockers and Aldosterone to Renin Ratio: A Randomized Controlled Trial and Observational Data 133
Abnormalities of insulin receptors in spontaneously hypertensive rats 130
Computed Tomography and Adrenal Venous Sampling in the Diagnosis of Unilateral Primary Aldosteronism 130
Vasculite dei vasa-nervorum: risposta alla terapia immunosoppressiva. Case Report 126
Role of Aldosterone in Insulin Resistance: Fact of Fantasy 124
Aldosterone and the heart: still an unresolved issue? 121
Aldosterone, Organ Damage, and Dietary Salt 120
Effects of angiotensin II (ANG II) infusion on insulin receptor binding and gene expression in the kidney of normal and diabetic rats 120
Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension 119
Long-Term Renal and Cardiac Outcomes after Stenting in Patients with Resistant Hypertension and Atherosclerotic Renal Artery Stenosis 119
Relationships of plasma renin levels with renal function in patients with primary aldosteronism 119
Editorial comment from Dr Catena, Dr Colussi, and Dr Sechi to preoperative masse renal damage in japanese patients with primry aldosteronism: identification of predictors for chronic kidney disease manifested after adrenalectomy. 115
Omega-3 Fatty Acids: from Biochemistry to their Clinical Use in the Prevention of Cardiovascular Disease 115
The emergent cardiovascular risk factors and organ damage in arterial hypertension 114
Early renal failure as a cardiovascular disease: Focus on lipoprotein(a) and prothrombotic state 114
Elevated Blood Pressure in Children of Cardiovascular Risk Mothers: Could Maternal Folic Acid Be the Link? 114
Benzodiazepines regulate the vascular tone vie an endothelium-independent mechanism 114
Prohypertensive effect of insulin: possible role of the sympathetic system 113
Glucose metabolism and insulin receptor binding and mRNA levels in tissues of Dahl hypertensive rats 113
The Metabolic Syndrome and the Membrane Content of Polyunsaturated Fatty Acids in Hypertensive Patients 113
Treatment of primary aldosteronism and organ protection 113
Predictors of target-organ damage in hypertension: role of lipoprotein(a) [Lp(a)] and apo(a) isoforms 112
Benzodiazepines: an old class of new antihypertensive drugs? 112
Fish Meal Supplementation and Ambulatory Blood Pressure in Patients With Hypertension: Relevance of Baseline Membrane Fatty Acid Composition 111
Pre-Procedural Statin Use Is Associated with Improved Long-Term Survival and Reduced Major Cardiovascular Events in Patients Undergoing Carotid Artery Stenting: A Retrospective Study 111
Abnormalities of glucose metabolism in patients with early renal failure 110
Kidney in primary aldosteronism: a key determinant of treatment outcome 110
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 110
Spontaneous restoration of sinus rhythm after cardiac surgery 109
Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance 109
Involvement of endothelium-dependent and -independent mechanisms in midazolam-induced vasodilation 109
Salt, Aldosterone, and Parathyroid Hormone: What Is the Relevance for Organ Damage? 108
Benign familial macrocytosis 107
Prevalence and determinants of resistant hypertension in a sample of patients followed in Italian hypertension centers: Results from the MINISAL-SIIA study program 107
Nonalcoholic fatty liver disease, adiponectin and insulin resistance in dipper and nondipper essential hypertensive patients 106
Salt, hypertension, and cardiovascular disease 106
Relationship of Plasma Renin With a Prothrombotic State in Hypertension: Relevance for Organ Damage 106
Cardiovascular outcomes in patients with primary aldosteronism after treatment 106
Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension 105
Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus 105
Intrarenal Vascular Resistance is Associated with a Prothrombotic State in Hypertensive Patients 104
Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension 103
Abnormalities of coagulation in hypertensive patients with early renal failure: association with cardiovascular events 102
Alcohol-induced endothelial changes are associated with oxidative stress and are rapidly reversed after withdrawal 102
Renal function in primary aldosteronism 101
Cardiorenal end points in a trial of aliskiren for type 2 diabetes. 101
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 101
Autonomic dysfunction in hyperadrenergic orthostatic hypotension 101
Nonalcoholic fatty liver disease in primary aldosteronism: a pilot study 100
Elevated homocysteine levels are associated with the metabolic syndrome and cardiovascular events in hypertensive patients 100
Moderate alcohol consumption is associated with left ventricular diastolic dysfunction in nonalcoholic hypertensive patients 100
Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension 99
Diabetes, diabetic complications, and blood pressure targets 99
Potassium-sparing diuretics in hypertension 98
Effects of antihypertensive drugs on alcohol-induced functional responses of cultured human endothelial cells. 98
The vascular response to vasodilators is related to the membrane content of polyunsaturated fatty acids in hypertensive patients 98
The SPARTACUS Trial: Controversies and Unresolved Issues 98
Validation of an easy questionnaire on the assessment of salt habit: the MINISAL-SIIA Study Program 98
Insulin receptors and renal sodium handling in hypertensive fructose-fed rats 96
Effects of the consumption of fish meals on the carotid IntimaMedia thickness in patients with hypertension: a prospective study 96
Association of Post-Saline Load Plasma Aldosterone Levels with Left Ventricular Hypertrophy in Primary Hypertension 96
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società  Italiana di Medicina Interna) Study 96
The dual role of the kidney in primary aldosteronism: key determinant in rescue from volume expansion and persistence of hypertension 95
Carotid artery stiffness is related to hyperinsulinemia and insulin-resistance in middle-aged, non-diabetic hypertensive patients 94
Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes 94
Abnormalities of coagulation in hypertensive patients with early renal failure: association with cardiovascular events 93
Plasma Parathyroid Hormone Is Independently Related to Nocturnal Blood Pressure in Hypertensive Patients: The Styrian Hypertension Study 93
Glucose metabolism in early renal failure 92
Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment 92
Insulin sensitivity in patients with primary aldosteronism: a follow-up study 92
A Prothrombotic State is Associated with Early Arterial Damage in Hypertensive Patients 91
Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment 91
Uricaemia and left ventricular mass in hypertensive patients 91
The Rising Burden of Hypertensive Renal Disease in Low-Income Countries: Is it Time to Take Action? 91
Relationship between bone turnover and left ventricular function in primary hyperparathyroidism: The EPATH trial 91
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort 90
Association of serum lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension 89
Low serum 25-hydroxyvitamin D levels are associated with left ventricular hypertrophy in essential hypertension 89
NON-ALCOHOLIC FATTY LIVER DISEASE IS NOT ASSOCIATED WITH VITAMIN D DEFICIENCY IN ESSENTIAL HYPERTENSION 89
Relationships of plasma lipoprotein(a) levels with insulin resistance in hypertensive patients 88
New risk factors for atherosclerosis in hypertension: focus on the prothrombotic state and lipoprotein(a) 88
Mineralocorticoid Receptor Antagonists and Clinical Outcomes in Primary Aldosteronism: As Good as Surgery? 88
Subclinical carotid artery disease and plasma homocysteine levels in patients with hypertension 88
Low-grade inflammation and tryptophan-kynurenine pathway activation are associated with adverse cardiac remodeling in primary hyperparathyroidism: The EPATH trial 88
Ambulatory arterial stiffness indices and non-alcoholic fatty liver disease in essential hypertension 88
Response to "plasma Homocysteine Levels and Endothelial Dysfunction in Cerebro-and Cardiovascular Diseases in the Metabolic Syndrome" 88
Primary hyperparathyroidism in pregnancy 88
A prothrombotic state is associated with increased carotid intima-media thickness in hypertension 87
Plasma glucose levels and left ventricular diastolic function in nondiabetic hypertensive patients 87
Plasma parathyroid hormone and cardiovascular disease in treatment-naive patients with primary hyperparathyroidism: The EPATH trial 87
Oxidative Stress Is Activated by Free Fatty Acids in Cultured Human Hepatocytes 87
Increased serum lipoprotein(a) levels in patients with early renal failure 86
Renal hyperfiltration and increased prevalence of cystic disease in patients with primary aldosteronism 86
Associazione dell’ispessimento miointimale carotideo con uno stato protrombotico in pazienti ipertesi 86
Association of aldosterone with left ventricular mass in hypertension: interaction with plasma fibrinogen levels 86
Totale 10.504
Categoria #
all - tutte 69.861
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.861


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.194 0 0 0 0 0 0 0 0 0 0 739 455
2019/20205.946 286 278 183 819 413 1.098 706 731 379 502 108 443
2020/20213.703 107 394 93 497 97 497 198 431 642 131 432 184
2021/20222.474 103 289 98 182 69 88 145 160 26 414 474 426
2022/20232.604 371 118 36 299 234 781 11 166 377 49 88 74
2023/2024762 141 72 55 42 167 93 26 21 105 34 6 0
Totale 22.242